Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease. - Wikidata - wikimedia - TriplyDB

Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease.

Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease.

http://www.wikidata.org/entity/Q51052485

about

Renalase is a novel, soluble monoamine oxidase that regulates cardiac function and blood pressure.Oxidative stress and the use of antioxidants in diabetes: linking basic science to clinical practice.Role of Superoxide Dismutase 2 Gene Ala16Val Polymorphism and Total Antioxidant Capacity in Diabetes and its Complications Soy-based renoprotection The molecular mechanisms of hemodialysis vascular access failure Mitochondria: a new therapeutic target in chronic kidney disease Effect of redox modulating NRF2 activators on chronic kidney disease Dietary antioxidents and oxidative stress in predialysis chronic kidney disease patients Oxidative stress and nucleic acid oxidation in patients with chronic kidney disease Chronic kidney disease influences multiple systems: describing the relationship between oxidative stress, inflammation, kidney damage, and concomitant disease Maintenance of hypertensive hemodynamics does not depend on ROS in established experimental chronic kidney disease Stress, oxidative injury and disease Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases C3a receptor antagonist ameliorates inflammatory and fibrotic signals in type 2 diabetic nephropathy by suppressing the activation of TGF-β/smad3 and IKBα pathway Sodium potassium adenosine triphosphatase (Na/K-ATPase) as a therapeutic target for uremic cardiomyopathy.Inhibition of the purinergic P2X7 receptor improves renal perfusion in angiotensin-II-infused rats.Polymorphisms in genes encoding antioxidant enzymes (SOD2, CAT, GPx, TXNRD, SEPP1, SEP15 and SELS) and risk of chronic kidney disease in Japanese - cross-sectional data from the J-MICC study.Multivariate analysis of matrix-assisted laser desorption/ionization mass spectrometric data related to glycoxidation products of human globins in nephropathic patients.Serum C-reactive protein and thioredoxin levels in subjects with mildly reduced glomerular filtration rate.The uremic toxin 3-indoxyl sulfate is a potent endogenous agonist for the human aryl hydrocarbon receptor.Aging and chronic kidney disease: the impact on physical function and cognition.An adsorbent monolith device to augment the removal of uraemic toxins during haemodialysis.Prevalence of atrial fibrillation and its predictors in nondialysis patients with chronic kidney disease Modulation of angiotensin II-induced inflammatory cytokines by the Epac1-Rap1A-NHE3 pathway: implications in renal tubular pathobiology.Hepatocyte nuclear factor 1 and hypertensive nephropathy.Kidney dysfunction in patients with pulmonary arterial hypertension Glutathione S-transferase Mu 2-transduced mesenchymal stem cells ameliorated anti-glomerular basement membrane antibody-induced glomerulonephritis by inhibiting oxidation and inflammation Inflammation and the osteogenic regulation of vascular calcification: a review and perspective.Oxidative stress and inflammation in renal patients and healthy subjects Low-dose aspirin for prevention of cardiovascular disease in patients with chronic kidney disease.Ascorbic acid or L-arginine improves cutaneous microvascular function in chronic kidney disease.Serum albumin and kidney function decline in HIV-infected women Conformational change in transfer RNA is an early indicator of acute cellular damage Assessment of vascular function in patients with chronic kidney disease.Inflammation, oxidative stress, glomerular filtration rate, and albuminuria in elderly men: a cross-sectional study.Advanced glycation in health and disease: role of the modern environment.Cardiovascular co-morbidity in chronic kidney disease: Current knowledge and future research needs.Paricalcitol reduces oxidative stress and inflammation in hemodialysis patients.Indoxyl sulfate-induced endothelial dysfunction in patients with chronic kidney disease via an induction of oxidative stress Relationship between retinal blood flow and renal function in patients with type 2 diabetes and chronic kidney disease

P2860

Q24521489-00D8419D-4346-4AE3-B568-0EB7CDC1F5A1 Q24805374-09F7EA7E-DFBB-4453-BBA2-7BBB2BA15269 Q26747751-1C93F43F-A704-4162-9D8E-6E89C1714675 Q26751544-6EAC3482-D371-49AD-859D-91349B67BB08 Q26775058-5AE81669-6DEF-4063-99F1-CFF3FDC251E4 Q26776397-B25B7FCD-66F1-4D39-90C9-48F0D766238A Q26827726-F382B8BC-C28B-4CDF-B149-A4039FB156B9 Q26991521-55D4B3DF-6EFC-400E-91AD-204C8BF5721C Q27006908-4D7CC5D9-7BD9-4D0B-9F0F-4CF8A1FBB81D Q27008315-946FDC54-0AC9-474D-9445-7E66253266CD Q27322607-8785C431-525A-4896-840F-5A74EC04DE5A Q28080864-C6A8C4C2-AC2A-415C-8A44-D59FE4287C5D Q28388335-FC587637-2DC1-4C13-A2C8-446B5F836AC2 Q28545168-76928277-039B-4B1A-892F-C592E69E1370 Q30235107-B7745572-1C9E-4262-91AF-E156124AE78A Q30384751-6AD5B81B-B7E9-495E-8157-39DEC6CB8DD6 Q30656525-930C78CF-3A30-4254-A102-1750B2DF19D9 Q31107732-88EB2ABD-48AE-4A03-93F4-7F94DDF79384 Q33566245-55B77179-94AD-47F6-974F-F71BCB7B49B6 Q33587787-37F2410D-AC3A-4DF5-B82E-229155200D82 Q33597949-2C7DD145-CC9F-4019-B51C-05F50E24203F Q33663437-C0247614-5F90-4C98-BF76-D72F01A5352F Q33684173-5DBD722E-6748-4D22-BE4D-E93CE43C915C Q33701556-D25F1DEC-7622-471B-B8D5-08CE3B6064CB Q33734218-F0266A35-E018-4FB7-B130-CBF0BECA0752 Q33738621-D052B75C-8778-4F53-BD70-840504EE4D43 Q33746135-C69AB315-FD19-4386-ACD1-1489B90FBAC3 Q33782750-64DD0060-0E78-4E3C-B088-B24C9F6D28D1 Q33987664-3A2458CF-440D-4708-B8E2-92BE2CE6152A Q34005232-C3A701AB-6500-40BB-A440-FB5E3E3B5C76 Q34008329-B9E3B95E-0C33-4B42-90AE-E8E93E277A73 Q34254770-5359977A-A8BB-46F9-9668-7FB3023ABF72 Q34260059-2457996D-B814-4845-9368-85BB77A41FDA Q34323504-353AB968-8D68-4899-BC7E-1630BD70B40E Q34422837-855B563A-ECA4-4D08-A381-4725585ABABB Q34436007-DD85BFA7-B33E-4F25-8014-39713F284CA1 Q34453236-0A699E7A-B667-483C-863A-158FB84C4AC4 Q34491713-B150B159-6871-472D-ACED-3E0C9E78E950 Q34497254-8F930B0E-B3DC-4235-BA33-43D2621DAB5D Q34498076-2730214C-80C6-41B5-9EE2-3A0B60116ED5

P2860

Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease.

http://www.wikidata.org/entity/Q51052485

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh-hant

name

Increased prevalence of oxidan ...... severe chronic kidney disease.

@en

Increased prevalence of oxidan ...... severe chronic kidney disease.

@nl

type

label

Increased prevalence of oxidan ...... severe chronic kidney disease.

@en

Increased prevalence of oxidan ...... severe chronic kidney disease.

@nl

prefLabel

Increased prevalence of oxidan ...... severe chronic kidney disease.

@en

Increased prevalence of oxidan ...... severe chronic kidney disease.

@nl

P1433

Q51052485-26770852-B2FB-48FD-B8DB-A57D60C03AAD

P1476

Q51052485-3759FCC2-51FD-4CD3-B405-CD2DE1A44ABF

P2093

Q51052485-2492C36D-E683-4ABD-B293-3A7653EA315A

Q51052485-7DEE2D91-2B8B-4D17-8B29-4A25B55BA71B

Q51052485-A462CCB4-C4E7-4325-88A8-C497F2CDD5A4

Q51052485-A75D26F4-2F13-4FA7-929F-811B1D03D58B

Q51052485-B46B7363-A75B-4986-A397-7C769B54808F

Q51052485-C5E3ABBC-2D27-4A8D-A899-3E52A48CE5DC

Q51052485-ED25581E-F230-4348-9D86-32F5716E74E7

P2888

Q51052485-7E8C8C5D-FBEB-4650-BF46-EFA8168AEC51

P304

Q51052485-E7448DBE-0087-4BFC-BEE7-D225F046BC7A

P31

Q51052485-B43FDCA7-DAC9-42C7-8F3B-01E8E86003C3

P356

Q51052485-19356D6E-5DFA-4CDF-AC9C-375F8C6A8DC9

P407

Q51052485-D693B8D4-52F5-427E-B896-88B83A967E06

P433

Q51052485-98AE7093-A475-4CB3-AA06-4DFF884F4EB5

P478

Q51052485-1406D8CD-0FA3-4476-B5AA-E62B6E851268

P577

Q51052485-7AEA5D40-FBB1-4B1F-BF93-29F0BE44232B

P5875

Q51052485-0EDA14F3-0EA7-4067-9E03-4E1546CCF5F9

P6179

Q51052485-BC85D021-E6F7-40A5-A28D-39D92A74A6D5

P698

Q51052485-FD8B3978-F6E3-462B-926B-C553A3100163

P921

Q51052485-A5C0C690-A5BA-4CD9-9146-CE1B37D29003

P356

J.1523-1755.2004.00465.X

P1433

Kidney International

P1476

Increased prevalence of oxidan ...... severe chronic kidney disease.

@en

P2093

B Payson Oberg

http://www.w3.org/2001/XMLSchema#string

Elizabeth McMenamin

http://www.w3.org/2001/XMLSchema#string

Ellen McMonagle

http://www.w3.org/2001/XMLSchema#string

F Lee Lucas

http://www.w3.org/2001/XMLSchema#string

Jason Morrow

http://www.w3.org/2001/XMLSchema#string

Jonathan Himmelfarb

http://www.w3.org/2001/XMLSchema#string

T Alp Ikizler

http://www.w3.org/2001/XMLSchema#string

P2888

j.1523-1755.2004.00465.x

P304

1009-1016

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1523-1755.2004.00465.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

65

http://www.w3.org/2001/XMLSchema#string

P577

2004-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8779755

http://www.w3.org/2001/XMLSchema#string

P6179

1014746247

http://www.w3.org/2001/XMLSchema#string

P698

14871421

http://www.w3.org/2001/XMLSchema#string

P921